MetaCap

InfuSystems (INFU) vs SS Innovations International (SSII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

InfuSystems (INFU) has outperformed SS Innovations International (SSII) over the past year, gaining 51.7% versus a loss of 78.7%. InfuSystems is the larger company by market cap ($287.5 million vs $254.9 million), about 1.1 times the size, while SS Innovations International is growing revenue faster (+105.7% vs +6.4%). InfuSystems converts more of its revenue into profit, with a net margin of 4.6% versus -28.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

INFU+51.69%SSII-78.69%
+69%-9%-86%
Nov 21, 20251 yearNov 20, 2026
INFU+139.17%SSII-66.13%
+217%+56%-106%
Aug 5, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

INFU versus SSII key metrics
MetricINFUSSII
Share price$14.35$1.27
Market cap$287.48M$254.86M
1-day change+2.06%-0.78%
YTD return+59.98%-77.64%
1-year return+51.69%-78.69%
5-year return-15.93%—
P/E ratio (TTM)32.61—
Forward P/E25.63—
EPS (TTM)$0.44$-0.07
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$143.44M$42.48M
Revenue growth (YoY)+6.36%+105.74%
Net income (latest FY)$6.63M$-12.13M
Gross margin55.98%46.00%
Operating margin8.31%-19.29%
Net margin4.62%-28.55%
52-week high$15.47$6.79
52-week low$7.29$1.12
Distance from 52-week high-7.24%-81.30%
Analyst consensusstrong_buynone
Avg. price target upside+28.92%+451.18%
Average volume136.60K86.18K
Shares outstanding20.03M200.68M
Employees461483
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • INFU has outperformed SSII by 130.4 percentage points over the past year.
  • InfuSystems is more profitable, keeping 4.6 cents of every revenue dollar as net income versus -28.5 cents for SS Innovations International.
  • SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs +6.36%).

About InfuSystems

INFU stock →

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions.

Health Care · Medical/Dental Instruments · 461 employees

About SS Innovations International

SSII stock →

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.

Health Care · Medical/Dental Instruments · 483 employees

INFU vs SSII FAQ

Which is bigger, InfuSystems or SS Innovations International?

InfuSystems (INFU) is larger, with a market capitalization of $287.48M compared with $254.86M for SS Innovations International (SSII).

Which stock has performed better over the past year, INFU or SSII?

INFU returned +51.69% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.

Are InfuSystems and SS Innovations International in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons